Literature DB >> 19264608

MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1.

Luke S Lambeth1, Yongxiu Yao1, Lorraine P Smith1, Yuguang Zhao1, Venugopal Nair2,1.   

Abstract

MicroRNAs (miRNAs) are a class of short RNAs that function as post-transcriptional suppressors of protein expression and are involved in a variety of biological processes, including oncogenesis. Several recent studies have implicated the involvement of miR-221 and miR-222 in tumorigenesis as these miRNAs are upregulated in a number of cancers and affect the expression of cell cycle regulatory proteins such as the cyclin-dependent kinase (cdk) inhibitor p27(Kip1). Marek's disease virus (MDV) is a highly oncogenic herpesvirus that affects poultry, causing acute neoplastic disease with lymphomatous lesions in several organs. MDV-encoded oncogenes such as Meq are directly implicated in the neoplastic transformation of T cells and have been well studied. More recently, however, the involvement of both host and virus-encoded miRNAs in the induction of MD lymphomas is being increasingly recognized. We analysed the miRNA expression profiles in the MDV-transformed lymphoblastoid cell line MSB-1 and found that endogenous miRNAs miR-221 and miR-222 were significantly upregulated. Demonstration of the conserved binding sites for these miRNAs in the chicken p27(Kip1) 3'-untranslated region sequence and the repression of luciferase activity of reporter constructs indicated that miR-221 and miR-222 target p27(Kip1) in these cells. We also found that overexpression of miR-221 and miR-222 decreased p27(Kip1) levels and that treatment with retrovirally expressed antagomiRs partially alleviated this suppression. These data show that an oncogenic herpesvirus, as in the case of many cancers, can exploit the miRNA machinery for suppressing cell cycle regulatory molecules such as p27(Kip1) in the induction and progression of T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264608     DOI: 10.1099/vir.0.007831-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Genome-wide analysis of aberrantly expressed circulating miRNAs in patients with coal workers' pneumoconiosis.

Authors:  Li Guo; Xiaoming Ji; Sheng Yang; Zhiguo Hou; Chen Luo; Jingjing Fan; Chunhui Ni; Feng Chen
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

2.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway.

Authors:  Shun Xu; Chunyi Xue; Jianping Li; Yingzuo Bi; Yongchang Cao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

4.  Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow.

Authors:  Ji Min Yu; Xiying Wu; Jeffrey M Gimble; Xiaoyan Guan; Michael A Freitas; Bruce A Bunnell
Journal:  Aging Cell       Date:  2011-02       Impact factor: 9.304

5.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

6.  The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site.

Authors:  Audrey Guillon-Munos; Ginette Dambrine; Nicolas Richerioux; Damien Coupeau; Benoît Muylkens; Denis Rasschaert
Journal:  BMC Mol Biol       Date:  2010-09-02       Impact factor: 2.946

7.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

8.  A cross-species analysis of microRNAs in the developing avian face.

Authors:  Kara E Powder; Yuan-Chieh Ku; Samantha A Brugmann; Rose A Veile; Nicole A Renaud; Jill A Helms; Michael Lovett
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

Review 9.  Involvement of eukaryotic small RNA pathways in host defense and viral pathogenesis.

Authors:  Julie Hicks; Hsiao-Ching Liu
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

10.  Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.

Authors:  Isabelle Gennart; Astrid Petit; Laetitia Wiggers; Srđan Pejaković; Nicolas Dauchot; Sylvie Laurent; Damien Coupeau; Benoît Muylkens
Journal:  Microorganisms       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.